For the 4Q, knee implant revenue decreased 2 percent to $20.6 million; extremities implant revenue increased 32 percent to $8.6 million; hip implant revenues increased 21 percent to $8.2 million; and biologic and spine segment revenues increased 7 percent to $7.4 million.
Exactech Chairman and CEO Bill Petty said the company’s shoulder business, its second-largest business segment, alone reached segment sales of $30 million in 2010. The company’s largest business segment, the knee business, was only up 1 percent during the year due to “industry softness” and marketing transitions in overseas markets, according to the news release.
Read the company news release about Exactech’s 4Q financial results.
Read other coverage about device company’s financial reports:
– Integra LifeSciences Reports $194.1M 4Q Revenue, 6% Increase
– NuVasive Reports 4Q Revenue of $129.3M, 20.9% Increase
– Alphatec Spine Reports 4Q Revenue of $46M, 38.4% Increase
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
